Skip to main content
. 2013 Jan 29;4(3):368–374. doi: 10.1007/s12975-012-0247-9

Fig. 5.

Fig. 5

A Sham, B SAH, C pitavastatin, D fasudil, and E combination treatment. Histopathological findings for the basilar artery were evaluated with eNOS staining (the same expansion). In the pitavastatin and combination treatment group, eNOS increased to the same extent as the sham group (see arrow, eNOS expressed in brown by endothelium) in comparison to the SAH group